Vasopressin antagonists in polycystic kidney diseaseTORRES, Vicente E.Kidney international. 2005, Vol 68, Num 5, pp 2405-2418, issn 0085-2538, 14 p.Article

Therapies to slow polycystic kidney diseaseTORRES, Vicente E.The Nephron journals. 2004, Vol 98, Num 1, pp e1-e7, issn 1660-8151Article

Strategies Targeting cAMP Signaling in the Treatment of Polycystic Kidney DiseaseTORRES, Vicente E; HARRIS, Peter C.Journal of the American Society of Nephrology. 2014, Vol 25, Num 1, pp 18-32, issn 1046-6673, 15 p.Article

Autosomal dominant polycystic kidney disease: the last 3 yearsTORRES, Vicente E; HARRIS, Peter C.Kidney international. 2009, Vol 76, Num 2, pp 149-168, issn 0085-2538, 20 p.Article

Retinal arterial and venous occlusions in patients with ADPKDQI QIAN; YOUNGE, Brian R; TORRES, Vicente E et al.Nephrology, dialysis, transplantation (Print). 2007, Vol 22, Num 6, pp 1769-1771, issn 0931-0509, 3 p.Article

Autosomal dominant polycystic kidney diseaseTORRES, Vicente E; HARRIS, Peter C; PIRSON, Yves et al.Lancet (British edition). 2007, Vol 369, Num 9569, pp 1287-1301, issn 0140-6736, 15 p.Article

Genetic diseases of the kidneyGUAY-WOODFORD, Lisa M; TORRES, Vicente E.Nephrology self-assessment program. 2005, Vol 4, Num 4, pp 166-231, issn 1536-836X, 66 p.Article

Treatment prospects for autosomal-dominant polycystic kidney diseaseQI QIAN; HARRIS, Peter C; TORRES, Vicente E et al.Kidney international. 2001, Vol 59, Num 6, pp 2005-2022, issn 0085-2538Article

Effectiveness of vasopressin V2 receptor antagonists OPC-31260 and OPC-41061 on polycystic kidney disease development in the PCK ratXIAOFANG WANG; GATTONE, Vincent; HARRIS, Peter C et al.Journal of the American Society of Nephrology. 2005, Vol 16, Num 4, pp 846-851, issn 1046-6673, 6 p.Article

Polycystic Liver DiseaseSCHNELLDORFER, Thomas; TORRES, Vicente E; ZAKARIA, Shaheen et al.Annals of surgery. 2009, Vol 250, Num 1, pp 112-118, issn 0003-4932, 7 p.Article

The pck rat : A new model that resembles human autosomal dominant polycystic kidney and liver diseaseLAGER, Donna J; QI QIAN; BENGAL, Rosemary J et al.Kidney international. 2001, Vol 59, Num 1, pp 126-136, issn 0085-2538Article

Frequency of Undiagnosed Cystic Lung Disease in Patients With Sporadic Renal AngiomyolipomasRYU, Jay H; HARTMAN, Thomas E; TORRES, Vicente E et al.Chest (American College of Chest Physicians). 2012, Vol 141, Num 1, pp 163-168, issn 0012-3692, 6 p.Article

Long-term ammonium chloride or sodium bicarbonate treatment in two models of polycystic kidney diseaseTORRES, Vicente E; COWLEY, Benjamin D; BRANDEN, Michael G et al.Experimental nephrology. 2001, Vol 9, Num 3, pp 171-180, issn 1018-7782Article

Cyclic nucleotide signaling in polycystic kidney diseaseXIAOFANG WANG; WARD, Christopher J; HARRIS, Peter C et al.Kidney international. 2010, Vol 77, Num 2, pp 129-140, issn 0085-2538, 12 p.Article

Vasopressin Directly Regulates Cyst Growth in Polycystic Kidney DiseaseXIAOFANG WANG; YANHONG WU; WARD, Christopher J et al.Journal of the American Society of Nephrology. 2008, Vol 19, Num 1, pp 102-108, issn 1046-6673, 7 p.Article

Duodenal diverticulosis in autosomal dominant polycystic kidney diseaseKUMAR, Sumedha; ADEVA, Magdalena; KING, Bernard F et al.Nephrology, dialysis, transplantation (Print). 2006, Vol 21, Num 12, pp 3576-3578, issn 0931-0509, 3 p.Article

Effect of calcium-sensing receptor activation in models of autosomal recessive or dominant polycystic kidney diseaseXIAOFANG WANG; HARRIS, Peter C; SOMLO, Stefan et al.Nephrology, dialysis, transplantation (Print). 2009, Vol 24, Num 2, pp 526-534, issn 0931-0509, 9 p.Article

The Cleaved Cytoplasmic Tail of Polycystin-1 Regulates Src-Dependent STAT3 ActivationTALBOT, Jeffrey J; XUEWEN SONG; XIAOFANG WANG et al.Journal of the American Society of Nephrology. 2014, Vol 25, Num 8, pp 1737-1748, issn 1046-6673, 12 p.Article

Blood Pressure in Early Autosomal Dominant Polycystic Kidney DiseaseSCHRIER, Robert W; ABEBE, Kaleab Z; MISKULIN, Dana C et al.The New England journal of medicine. 2014, Vol 371, Num 24, pp 2255-2266, issn 0028-4793, 12 p.Article

Genetic Variation of DKK3 May Modify Renal Disease Severity in ADPKDLIU, Michelle; SHI, Sally; PIERIDES, Alkis et al.Journal of the American Society of Nephrology. 2010, Vol 21, Num 9, pp 1510-1520, issn 1046-6673, 11 p.Article

Randomized Clinical Trial of Long-Acting Somatostatin for Autosomal Dominant Polycystic Kidney and Liver DiseaseHOGAN, Marie C; MASYUK, Tetyana V; ROSSETTI, Sandro et al.Journal of the American Society of Nephrology. 2010, Vol 21, Num 6, pp 1052-1061, issn 1046-6673, 10 p.Article

Sirolimus Reduces Polycystic Liver Volume in ADPKD PatientsQI QIAN; HUI DU; KING, Bernard F et al.Journal of the American Society of Nephrology. 2008, Vol 19, Num 3, pp 631-638, issn 1046-6673, 8 p.Article

Mutations in PRKCSH cause isolated autosomal dominant polycystic liver diseaseAIRONG LI; DAVILA, Sonia; FURU, Laszlo et al.American journal of human genetics. 2003, Vol 72, Num 3, pp 691-703, issn 0002-9297, 13 p.Article

Magnetic resonance measurements of renal blood flow as a marker of disease severity in autosomal-dominant polycystic kidney diseaseKING, Bernard F; TORRES, Vicente E; BENNETT, William M et al.Kidney international. 2003, Vol 64, Num 6, pp 2214-2221, issn 0085-2538, 8 p.Article

The position of the polycystic kidney disease 1 (PKD1) gene mutation correlates with the severity of renal diseaseROSSETTI, Sandro; BURTON, Sarah; WINEARLS, Christopher G et al.Journal of the American Society of Nephrology. 2002, Vol 13, Num 5, pp 1230-1237, issn 1046-6673Article